Details of the Drug Formulations

General Information of Drug (ID: DM8ZXT6)

Drug Name
Oxymetazoline Drug Info
Synonyms
Hazol; Iliadin; Nafrine; Navasin; Navisin; Nezeril; Oximetazolina; Oximetazolinum; Oxylazine; Oxymetazolinum; Oxymethazoline; Oxymetozoline; Rhinofrenol; Rhinolitan; Sinerol; Dristan Long Lasting Mentholated Nasal Spray; Dristan Long Lasting Nasal Mist; Drixoral Nasal Solution; Oxymeta zoline; Oxymetazoline hydrochloride crystalline; Afrin Cherry 12 Hour Nasal Spray; Afrin Extra Moisturizing 12 Hour Nasal Spray; Afrin Original 12 Hour Nasal Spray; Afrin Original 12 Hour Nose Drops; Afrin Original 12 Hour Pump Mist; Afrin Sinus 12 Hour Nasal Spray; Duramist Plus Up To 12 Hour Nasal Decongestant Spray; Genasal Nasal Spray Up to 12 Hour Relief; H 990; Nasal Relief 12 Hour Nasal Spray; Nostrilla 12 Hour Nasal Decongestant; Vicks Sinex 12 Hour Nasal Spray; Vicks Sinex 12 Hour Ultra Fine Mist for Sinus Relief; Decongestant (TN); Neo-Synephrine 12 Hour Spray; Operil (TN); Oximetazolina [INN-Spanish]; Oxymetazoline (INN); Oxymetazoline [INN:BAN]; Oxymetazolinum [INN-Latin]; Visine L.R; Visine L.R.; Phenol, 6-tert-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethyl-(7CI,8CI); Phenol, 3-[(4,5-dihydro-1H-imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethyl-(9CI); 2-(4-tert-Butyl-2,6-dimethyl-3-hydroxybenzyl)-2-imidazoline; 3-(4,5-dihydro-1H-imidazol-2-ylmethyl)-2,4-dimethyl-6-tert-butyl-phenol; 3-[(4,5-Dihydro-1H-imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethylphenol; 6-t-Butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol; 6-tert-Butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol; 6-tert-Butyl-3-(4,5-dihydro-1H-imidazol-2-ylmethyl)-2,4-dimethylphenol
Indication
Disease Entry ICD 11 Status REF
Arrhythmia BC9Z Approved [1]
Eye inflammation 9A02 Approved [2]
Fecal incontinence ME07 Approved [1]
Nasal congestion MD11.9 Approved [2]
Therapeutic Class
Nasal Decongestants
Cross-matching ID
PubChem CID
4636
ChEBI ID
CHEBI:7862
CAS Number
1491-59-4
TTD ID
D09EBS
INTEDE ID
DR1224
ACDINA ID
D01309

Full List of Drug Formulations Containing This Drug

Oxymetazoline 1% cream
Company Formulation ID FDA Description
Epi Hlth F23856 Sodium Citrate Dihydrate; Citric Acid Anhydrous; Disodium Edetate Dihydrate; Butylated Hydroxytoluene; Anhydrous Lanolin; Medium Chain Triglycerides; Diisopropyl Adipate; Oleyl Alcohol; Polyethylene Glycol 300; Peg-6 Stearate; Glycol Stearate; Peg-32 Stearate; Cetostearyl Alcohol; Ceteareth-6; Stearyl Alcohol; Ceteareth-25; Methylparaben; Propylparaben; Phenoxyethanol; Purified Water
------------------------------------------------------------------------------------
Oxymetazoline 0.1% solution
Company Formulation ID FDA Description
Rvl Pharms F23855 Calcium Chloride; Hydrochloric Acid; Hypromellose; Magnesium Chloride; Potassium Chloride; Sodium Acetate; Sodium Chloride; Sodium Citrate; Water
------------------------------------------------------------------------------------
Oxymetazoline 0.1mg/spray spray
Company Formulation ID FDA Description
St Renatus F24297 Citric Acid; Sodium Citrate; Hydroxyethylcellulose; Benzylalcohol; Water; Sodium Hydroxide; Hydrochloric Acid
------------------------------------------------------------------------------------
Oxymetazoline 6mg/spray spray
Company Formulation ID FDA Description
St Renatus F24417 Citric Acid; Sodium Citrate; Hydroxyethylcellulose; Benzylalcohol; Water; Sodium Hydroxide; Hydrochloric Acid
------------------------------------------------------------------------------------

References

1 Oxymetazoline FDA Label
2 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015